Клаус Кёнлейн - Вирусомания

321 Tahi, Djamel, AJDS-The Doubt, Arte Television, 14 March 1996, see www.torstenengelbrecht.com/de/artikel _ medien.html

322 Lang, Serge, Challenges; Springer, New York, 1998, pp. 616 - 617

323 Geshekter, Charles; Mhlongo, Sam; Kohnlein, Claus, AJDS, Medicine and Public Health: The Scientific Value of Thabo Mbeki's Critique of AIDS Orthodoxy, Vortrag auf dem 47th Annual Meeting of the African Studies Association New Orleans, Louisiana, 11 November 2004

324 Duesberg, Peteffl; KoeHIVlein, Claus; Rasnick, David, The Chemical Bases of the Various AIDS Epidemics: Recreational Drugs, Anti-viral Chemotherapy and Malnutrition, Journal of Biosciences, June 2003, pp. 385 - 386

325 Katzenellenbogen, Jonathan, Third of Africans Undernourished, Business Day (Johannesburg), 20 August 2004

326 Shenton, Joan, Positively False: Exposing the Myths Around HIV and AJDS, I.B. Tauris/ St.Martin's Press, 1998

327 Fenton, Lynda, Preventing HIV/AJDS through poverty reduction: the only sustainable solution?, Lancet, 2004, 25 September 2004, pp. 1186 - 1187

Глава 4

Гепатит С: токсины, такие как алкоголь, героин и лекарственные средства, отпускаемые по рецепту, достаточны для пояснений

1 Kohnlein, Claus, Hepatitis C-the epidemic that never was?, British Medical Journal (online), 7 March 2002, see bmj.bmijournals.corn/cgi/eletters/324/7335/450

2 Larkin, Marylinn, Jay Hoofnagle: soldiering on against viral hepatitis, Lancet, 27 September 1997, p. 938

3 lntron-A, Rote Liste, 2005, p. 51025

4 Welche Nebenwirkungen haben Interferone?, Website of the Krebsinformationsdienst of the Deutsches Krebsforschungszentrum DKFZ (German Cancer Research Centre) in Heidelberg

5 Erstmals Vermehrung des Hepatitis C Virus im Labor moglich, press release of the Ruprechts Karl-University in Heidelberg, 6 October 2004

6 Larkin, Marylinn, Jay Hoofnagle: soldiering on against viral hepatitis, Lancet, 27 September 1997, p. 938

7 Alter, Harvey, Transmissible agent in non-A, non-B hepatitis, Lancet, 4 March 1978, pp. 459 - 463

8 Houghton, Michael; Bradley, Daniel, Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis, British Medical Bulletin, April 1990, pp. 423 - 441

9 Chiron Advances Hepatitis C Vaccine Development Program, press release, Chiron Vaccines, 14 January 2004

10 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 84

11 KiiHIVlein, Claus, Hepatitis C-the epidemic that never was?, British Medical Journal (online), 7 March 2002, see bmj.bmjjournals.com/cgi/eletters/324/7335/450

12 Chiron Reports First-Quarter 2005 Pro-Forma Earnings of 4 Cents Per Share, GAAP Loss of 5 Cents Per Share, press release of the Chiron Corporation, 27 April 2005

13 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, p. 84

14 Crowe, David, The ABCs of Hepatitis, Alive Magazine, May 2004

15 Chen, Zheng, Hepatitis C virus (HCV) specific sequences are demonstrable in the DNA fraction of peripheral blood mononuclear cells from healthy, anti-HCV antibody-negative individuals and cell lines of human origin, European Journal of Clinical Chemistry and Clinical Biochemistry, December 1997, pp. 899 - 905

16 Duesberg, Peter, Inventing the AIDS Virus, Regnery Publishing, 1996, pp. 84 - 85

17 Syringe Exchange Programs, CDC's Website

18 Hagan, Holly, Syringe exchange and risk of infection with hepatitis B and C viruses, American Journal of Epidemiology, 1 February 1999, pp. 203 - 213

19 Crowe, David, The ABCs of Hepatitis, Alive Magazine, May 2004

20 Thomas, David, The natural history of hepatitis C virus infection: host, viral, and environmental factors, Journal of the American Medical Association, 26 July 2000, p. 450

21 Hoofnagle, Jay, Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B, New England Journal of Medicine, 26 October 1995, pp. 1099 - 105

22 Castillo, Inmaculada, Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown, Journal of Infectious Diseases, 1 January 2004, pp. 7 - 14

23 Thomas, David, The natural history of hepatitis C virus infection: host, viral, and environmental factors, Journal of the American Medical Association, 26 July 2000, p. 450

24 Kohnlein, Claus, Virale Seuchen, die es gar nicht gibt. BSE/ AIDS/Hepatitis C, Raum & Zeit, 111/2001, p. 23

25 Laufs, Rainer, Was bedeutet der Befund "HCV-Antikiirper positiv"?, Deutsches Arzteblatt, 4 February 1994, p.A286

26 Siegmund-Schultze, Nicola, Die stille Seuche. 500 000 Deutsche sind mit Hepatitis C infiziertnun werden die Aussichten auf einen Impfstoff besser, Süddeutsche Zeitung, 13 October 2004, p. 10

27 Laufs, Rainer, Was bedeutet der Befund "HCV-Antikorper positiv"?, Deutsches Arzteblatt, 4 February 1994, p.A287

28 Hadziyannis, Stephanos, Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy, Journal of Hepatology, February 2002, pp. 280 - 282

29 Comment by the Deutsche Leberhilfe e. V. (German Liver Aid) to our book "Virus Mania", published on the Amazon.de website on 16 June 2006, see www.amazon.de/gp/product/customer-

reviews/3891891474/ref=cm _ cr _ dp _ 2 _ 1!303-37872289015431?ie=UTF8&customerreviews.sort%5Fby=- SubrnissionDate&n=299956

30 Comment from the authors of this book to the comment by the Deutsche Leberhilfe e. V. (German Liver Aid) to this book, published on _the website of Torsten Engelbrecht on 4 July 2006, see www.torstenengelbrecht.com/de/buch _ viruswaHIV.html

31 Seeff, Leonard, 45-year follow-up of hepatitis C virus infection in healthy young adults, Annals of Internal Medicine, January 2000, pp. 105 - 11

32 Schentke, Klaus-Ulrich, Leberschiiden durch Medikamente, Deutsche Medizinische Wochenschrift, 1995, Vol. 120, pp. 923 - 925

33 Personal e-mail communication, December 2005

34 See www.drruhland.com

35 Pamela Anderson expects death in a decade, CNN.com, 22 October 2003

36 Pamela Anderson launches hepatitis campaign, CTV.ca, 17 November 2002

37 Pamela Anderson was the Grand Marshal of the American Liver Foundation, www.clubpam.com

Глава 5

BSE: Эпидемия, которой никогда не было

1 Scholz, Roland, Phantom BSE-Gefahr. Irrwege von Wissenschaft und Politik im BSE-Skandal, Berenkamp, 2005

2 Riebsamen, Hans, BSE ist vergessen: Rare, medium oder well-done?, Frankfurter Allgemeine Sonntagszeitung, 17 November 2002, p. 6

3 Entwarnung: Creutzfeldt-Jakob-Krankheit fiillt aus, Manager Magazin (online), 12 January 2005

4 Venters, George, New variant Creutzfeldt-Jakob disease: the epidemic that never was, British Medical Journal, 13 October 2001, pp. 858 - 861

5 Ghani, Azra, Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility, Journal of the Royal Society Interface, 22 March 2005, pp. 19 - 31

6 Riebsamen, Hans, BSE ist vergessen: Rare, medium oder well-done?, Frankfurter Allgemeine Sonntagszeitung, 17 November 2002, p. 6

7 New Generation BSE test approved by CFIA, press release, Prionics AG, 16 June 2005

8 O'Brien, Jennifer, Prion finding offers insight into spontaneous protein diseases, News Release, University of California, San Francisco (UCSF), 29 July 2004, see www.pub.ucsf.edu/newsservices/releases/200407274 _?print

9 Mayr, Anton, BSE und Creutzfeldt-Jakob-Krankheit (CJD): Falsche Begriffe und falsche Assoziationen, Journal Med, 57/2001, p. 6

10 Scholz, Roland, Oberlegungen zur Genese der bovinen spongiformen Encephalopathie (BSE), Biolab-Website, see www.biolab-muenchen.de/index.html?rightftame=http://www.biolabmuenchen.de/bse/scholz01.htm